Hallaji, M., Allahyari, M., Fard-Esfahani, P. & Fayaz, S. (2024). Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules. (e739550). Iranian Biomedical Journal, (), e739550

Hallaji, M., Allahyari, M., Fard-Esfahani, P., & Fayaz, S. "Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules" .e739550 , Iranian Biomedical Journal, , 2024, e739550.

Hallaji, M., Allahyari, M., Fard-Esfahani, P., & Fayaz, S. (2024). 'Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules', Iranian Biomedical Journal, (), e739550.

Hallaji, M., Allahyari, M., Fard-Esfahani, P. & Fayaz, S., "Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules." Iranian Biomedical Journal, (2024): e739550,

Hallaji M., Allahyari M., Fard-Esfahani P., Fayaz S. Therapeutic Fc Fusion Proteins: Structural Design, Pharmacokinetic Properties, Post-Translational Modifications, and Clinically Approved Molecules. Iranian Biomedical Journal. 2024;():e739550.